Eu­rope buys 54,000 more dos­es of Bavar­i­an Nordic's mon­key­pox vac­cine as cas­es in­crease

The EU is back for more dos­es of mon­key­pox vac­cines af­ter see­ing thou­sands of more cas­es.

The Eu­ro­pean Com­mis­sion an­nounced Mon­day that it reached a deal with Bavar­i­an Nordic to buy an ad­di­tion­al 54,000 dos­es of the biotech’s mon­key­pox vac­cine af­ter a sub­stan­tial in­crease in mon­key­pox cas­es in the con­ti­nent.

This or­der and oth­ers pushed Bavar­i­an Nordic on Mon­day to al­so re­up its 2022 rev­enue guid­ance, which is now ex­pect­ed to be be­tween $368 mil­lion and $396 mil­lion (pre­vi­ous­ly it was es­ti­mat­ed to be be­tween $314 mil­lion and $341 mil­lion).

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER